Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05117008
Title Maintenance Belantamab Mafodotin (Blenrep) After B-cell Maturation Antigen-Directed Chimeric Antigen Receptor T-cell Therapy in Patients With Relapsed and/or Refractory Multiple Myeloma (EMBRACE)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Medical College of Wisconsin
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.